BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 840889)

  • 1. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP; Marosi J; Fischer J
    Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 10. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M; Antipa C; Cucu C
    Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved psychological status of children under DDAVP therapy for central diabetes insipidus.
    Waggoner RW; Slonim AE; Armstrong SH
    Am J Psychiatry; 1978 Mar; 135(3):361-2. PubMed ID: 626231
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
    Kinter LB; Beeuwkes R
    Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
    Fjellestad A; Czernichow P
    Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ; Wise PH; Harding PE
    Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.